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The cloning of the PKD1 and PKD2 genes has led to promising new insight into the mechanisms that are responsible for cyst
development in patients with autosomal dominant polycystic kidney disease. Although the dominant pattern of inheritance
would argue for haploinsufficiency, a gain of function, or a dominant negative mechanism, there is good evidence that
autosomal dominant polycystic kidney disease behaves like a recessive disease on a cellular level (two-hit mechanism of
cystogenesis). For testing of whether other pathomechanisms in addition to the two-hit hypothesis can explain cyst formation,
two transgenic rat lines that contain a truncated human polycystin-2 cDNA were generated. The protein product lacks almost
the entire COOH-terminus and mimics mutations that frequently are found in patients. The transgene-encoded mRNA could
be detected in multiple tissues of both transgenic lines, with the highest expression in the kidney. Both lines present with
renal cysts that originate predominantly from the proximal tubule; in the tubular epithelial cells, the epitope-tagged mutant
protein was detected in the brush border and in primary cilia. Further evidence of the involvement of primary cilia stems from
the finding of retinal degeneration in the transgenic rats and from the fact that stably transfected LLC-PK1 cells that inducibly
produced the truncated polycystin-2 protein elaborated shorter cilia. Other experimental approaches, such as a knock-in
strategy, will be necessary to validate these results, but this is the first preliminary evidence that cyst formation is due not only
to somatic mutations.
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A
t a prevalence of at least 1:1000 (1,2), autosomal dom-
inant polycystic kidney disease (ADPKD) is the most
common hereditary renal disorder. It is characterized
by the growth of numerous fluid-filled cysts within the paren-
chyma of the kidney, which eventually leads to the loss of renal
function, such that approximately 50% of affected individuals
develop end-stage renal failure by the age of 60 (3–5). A high
number of apoptotic figures in cyst-lining epithelial cells, in-
creased mitotic rates, and cyst formation in transgenic mice that
produce cell cycle–promoting proteins suggest that an imbal-
ance between cell proliferation and apoptosis plays a role in
cyst formation. Other abnormalities that are found in cyst wall
epithelia include a change in cell polarity, aberrant fluid secre-
tion, and a dysregulated synthesis of metalloproteinases and
tissue inhibitors of metalloproteinases (for review, see reference
[6]).
Genetically, ADPKD is a heterogeneous disease; in approxi-
mately 85% of patients, it is caused by mutations in the PKD1
gene, and in approximately 15% of patients, it is caused by
mutations in the PKD2 gene (7–10). Polycystin-2, the protein
that is encoded by the PKD2 gene, is a 968–amino acid protein
with six putative transmembrane domains; sequence homology
to voltage-activated calcium channels and to the Trp family of
calcium channels suggested already early on that it functions as
an ion channel (11). This hypothesis indeed was proved correct
later by patch-clamp and single-channel recordings that
showed that polycystin-2 functions as a high-conductance, non-
selective cation channel (for review, see reference [12]). So far,
most of the biochemical information is available on the COOH-
terminus of polycystin-2, which has been shown to interact
with polycystin-2 itself (13,14) and with -actinin (15), CD2AP
(16), mDia1 (17), Id2 (18), the inositol-1,4,5-triphosphate (IP3)
receptor (19), phosphofurin acidic cluster sorting protein–1
(PACS-1) and PACS-2 (20), polycystin-2 interactor, Golgi- and
endoplasmic reticulum–associated protein–14 (PIGEA-14) (21),
polycystin-1 (13,14), tropomyosin-1 (22), troponin I (23), and
transient receptor potential-canonical (TRPC1) (24). The intra-
cellular location of polycystin-2 is a matter of intense debate:
Not only arguments for its location in the endoplasmic reticu-
lum and the plasma membrane have been put forward (25), but
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mary cilium of renal epithelial cells (26,27).
One puzzling observation in the field concerns the fact that
ADPKD is inherited in a dominant manner, but cysts develop
only in a limited number of nephrons. This phenomenon has
been explained by the finding that cyst-lining cells suffer from
a somatic mutation in the allele of the respective PKD gene that
is not mutated in the germline. On a cellular level, ADPKD
therefore can be considered a recessive disease (for review, see
reference [28]). The two-hit model of cyst formation has been
supported further by a Pkd2 mutant mouse in which the so-
matic rearrangement of an unstable allele to a null allele leads
to cyst formation (29,30). However, a mutation in the second
allele of the same gene or in the alternate gene (a phenomenon
called trans-heterozygosity [31,32]) has not been found in 100%
of the investigated cysts, which may be due to the technically
challenging protocol of detecting mutations in very few cells or
because an additional pathway of cystogenesis exists. Because
many mutations in patients with ADPKD are predicted to lead
to the synthesis of a truncated protein, we decided to generate
transgenic rats that produce an epitope-tagged mutant polycys-
tin-2 protein that lacks almost the entire COOH-terminus. In
this study, we describe the phenotypic consequences in these
animals.
Materials and Methods
Expression Plasmids
The full-length human PKD2 cDNA (gift from Stefan Somlo, Yale
University School of Medicine, New Haven, CT) was cloned into the
KpnI/XbaI sites of pUC18. With the use of a PCR-based strategy, a
fragment that encoded an epitope from the influenza virus hemagglu-
tinin protein (HA-epitope) was inserted immediately upstream of the
stop codon. During the construction, the BsaAI site before the stop
codon was deleted, and an XhoI site was placed between the HA-
coding sequence and the stop codon. The sequence of the resulting
construct PKD2, HA reads as follows (the last three codons of PKD2 are
boldface; the sequence encoding the HA-epitope is italicized): 5- ...
GTC CAC GTC TAC CCA TAC GAT GTT CCA GAT TAC GCT CTC
GAG TGA. . . -3.
An analogous strategy was used to tag the polycystin-2 protein at the
COOH-terminus with a tail of six histidines. A ClaI site was introduced
after the last PKD2 codon, and again the BsaAI site before the stop
codon was deleted and an XhoI site was inserted between the His6-
encoding sequence and the stop codon. The sequence of the resulting
construct PKD2, His reads as follows (the last three codons of PKD2 are
boldface; the sequence encoding the 6 histidines is italicized): 5- ...
GTC CAC GTC ATC GAT CGC GGC TCC CAC CAC CAC CAC CAC
CAC CTC GAG TGA. . . -3.
An HA-epitope–tagged mutant of the polycystin-2 protein that ex-
tended from amino acids 1 to 703 was created using an internal BglII
site in the PKD2 cDNA and an adaptor. During the construction, an
AflII site was placed between the PKD2 sequence and the sequence that
codes for the HA-epitope. The sequence of the resulting construct PKD2
(1–703), HA reads as follows (the last three codons of PKD2 are bold-
face; the sequence encoding the HA-epitope is italicized): 5- ...TCA
GAT CTT CTT AAG TAC CCA TAC GAT GTT CCA GAT TAC GCT
TAA. . . -3.
The PKD2, HA; the PKD2, His; and the PKD2 (1–703), HA fragments
were inserted into the eukaryotic expression plasmid pUHD 10-3 (gift
from H. Bujard, Zentrum fu ¨r Molekulare Biologie der Universita ¨t Hei-
delberg, Heidelberg, Germany). The correct orientation of the insert
was confirmed by restriction enzyme digestion and DNA sequencing.
Generation of Transgenic Rats, Genotype Analysis, and
Urine and Serum Chemistry
A 2.2-kbp cDNA fragment that encoded the HA-epitope–tagged
truncated human polycystin-2 protein extending from amino acids 1 to
703 was subcloned into a plasmid that was designed specifically for the
generation of transgenic animals. This plasmid, pUCTrans, contains a
cytomegalovirus (CMV) promoter upstream and the intron and poly-
adenylation signal of SV40 downstream of an EcoRI cloning site (Figure
1a). The transgenic cassette was removed from the plasmid using ClaI
and ApaLI, purified over an Elutip-D column (Schleicher and Schuell,
Dassel, Germany), and injected into the pronuclei of fertilized oocytes
that were harvested from Sprague-Dawley rats. Genomic DNA was
isolated from rat tails and subjected to Southern blot analysis according
to standard protocols (33). For detection of the transgene, 10 go f
genomic DNA was digested with BamHI and hybridized with a radio-
labeled 1.0-kbp BamHI fragment of the human PKD2 cDNA. For urine
and serum chemistry, individual rats were placed in metabolic cages
for 24 h to determine the daily urinary excretion of total protein and
albumin. Blood samples were taken in parallel for serum creatinine and
urea measurements. The rats received standard rat diet (containing 19%
protein) and had free access to tap water. All experiments were con-
ducted in accordance with the German Animal Protection Law and
were approved by the local government (Regierungspra ¨sidium
Karlsruhe, Germany).
Cell Culture and Transfections
HtTA-1 cells (HeLa cells that express the tetracycline-controlled
transactivator; gift from H. Bujard) (34) and LtTA-2,22 cells (LLC-PK1
cells that express the tetracycline-controlled transactivator) (35) were
cultured in DMEM with 10% FCS, 200 g/ml G418 (Life Technologies,
Karlsruhe, Germany), and 10 ng/ml (unless otherwise indicated) of
doxycycline (Sigma, Taufkirchen, Germany) to prevent the synthesis of
the protein of interest (tet-off system). For stable transfections, cells
were seeded into 25-cm
2 flasks. When the cells had reached approxi-
mately 70% confluence, they were transfected with 8 g of the expres-
sion plasmids pUHD 10-3/PKD2, HA or pUHD 10-3/PKD2 (1–703),
HA, respectively, as well as with 0.8 g of the selection plasmid pBabe
Puro (36) by using a calcium phosphate protocol (37). Sixteen hours
after the addition of the DNA, the cells were split onto 100-mm petri
dishes; 2 d later, the selection process was initiated with 0.5 g/ml of
puromycin (Calbiochem, Schwalbach, Germany). Individual colonies
were isolated and tested for the inducible expression of the full-length
and truncated polycystin-2 proteins.
Stably transfected HeLa cell lines that coexpressed either the full-
length and truncated polycystin-2 proteins or two differently tagged
full-length polycystin-2 proteins were established as follows. HtTA-1
cells that inducibly expressed the HA-epitope–tagged full-length or
truncated polycystin-2 proteins were co-transfected with the expression
plasmid pUHD10-3/PKD2, His and the selection plasmid pWE4 (38)
according to the poly-l-ornithine method (39). The selection was
started 72 h later with the addition of 300 g/ml of hygromycin
(Calbiochem). Resistant colonies were isolated and tested for the in-
ducible expression of the His-tagged full-length polycystin-2 protein.
Calcium Measurements
LLC-PK1 cells were grown for6di nt h epresence and absence of 1
g/ml of doxycycline before being transferred onto coverslips. Two to
2720 Journal of the American Society of Nephrology J Am Soc Nephrol 17: 2719–2730, 2006Figure 1. Transgenic rats with a truncated polycystin-2 protein develop polycystic kidney disease. (a) Schematic description of the
transgenic expression cassette (not drawn to scale; total length of the injected fragment was approximately 3.6 kbp). The cytomegalo-
virus (CMV) promoter/enhancer region controls the synthesis of a truncated human polycystin-2 protein of 703 amino acids in length
and an hemagglutinin protein (HA)-epitope at its COOH-terminus [PKD2 (1/703), HA]. To enhance the expression of the cDNA, an
intron and polyadenylation signal [poly(A)] of SV40 were inserted at the 3 end of the cassette. (b) The transgene-encoded mRNA was
detected by RNase protection assay with a probe directed against the 3-untranslated region (its specificity can be appreciated by the
fact that no signal was detected in the kidney of a normal Sprague-Dawley rat [SD]). After an 8-h exposure (Short exp), a clear signal
can be seen in the kidneys of both transgenic rats 111 and 247 (TGR 111 and TGR 247), whereas after a 14-d exposure (Long exp), the
widespread expression of the transgene becomes evident (top two panels). A RNase protection assay for the 18S RNA shows that the
RNA concentrations were determined correctly; tRNA served as a negative control. Ad, adrenal gland; Br, brain; He, heart; L. in, large
intestine; S. in, small intestine; Ki, kidney; Li, liver; Lu, lung; Pa, pancreas; Sa, salivary gland; Sp, spleen; Te, testis. (c) Serum creatinine
and urea concentrations in wild-type rats (E) and rats of transgenic line 247 (‚). Animals between 7 and 12 mo old were used for serum
analysis except for the two 15-mo-old rats indicated by arrows. (d) Sections through the kidneys of a normal SD rat and of both
transgenic rat lines (TGR 111, TGR 247) were stained with Goldner’s trichrome stain to demonstrate fibrotic tissue (green). The middle
panels show typical cortical sections of 5-mo-old transgenic rats, whereas the one on the far right shows a whole-kidney section from
a 3-mo-old rat with pronounced focal cyst formation and accompanying fibrosis. Bars  400 m (cortical sections in the first three
panels) and 2 mm (whole kidney on the far right).
J Am Soc Nephrol 17: 2719–2730, 2006 Truncated Polycystin-2 Causes PKD 27214 d after the cells were plated onto coverslips, they were washed twice
in imaging buffer that contained 150 mM NaCl, 5 mM KCl, 2.2 mM
CaCl2, 5 mM glucose, 10 mM HEPES (pH 7.4), and 1 mM MgCl2.
Subsequently, the cells were loaded for 30 min at room temperature in
imaging buffer to which 5 mM probenecid, 0.025% Pluronic (Invitro-
gen, Karlsruhe, Germany), and 5 M Fura-2 AM (Invitrogen) were
added. For stimulation of the cells with 10 M ATP, the cells were
washed twice with imaging buffer that contained probenecid and then
incubated for at least 15 min in the same buffer before the fluorescence
measurements started. For stimulation of the cells with ionomycin, the
cells were washed twice after loading with imaging buffer that con-
tained probenecid and incubated for at least 15 min in the same buffer
before new imaging buffer that lacked Ca
2 but contained 2 mM EGTA
was added. Once the fluorescence had stabilized, ionomycin was added
to a final concentration of 10 M. Fluorescence was measured by
alternating between the excitation wavelengths of 340 and 380 nm and
determining the emission every second for 10 min. Each curve repre-
sents measurements that were taken from eight coverslips that com-
prised 573 to 666 individual cells when cells were stimulated with ATP,
and from four to six coverslips that comprised 278 to 464 individual
cells when cells were exposed to ionomycin. Statistical significance of
the difference between the peak [Ca
2]i was calculated by subjecting
the values to a t test.
Immunostaining and Histologic Staining of Tissues
and Cells
Rats were perfused through the distal abdominal aorta with 4%
paraformaldehyde and 1 PBS for 3 min at a pressure of 200 mmHg.
Organs of interest were removed and immersed in 18% sucrose and 1
PBS before being frozen in liquid nitrogen or postfixed overnight in 4%
PFA and 1 PBS for paraffin embedding. The following primary anti-
bodies were used on cryosections: A mouse monoclonal anti-rat dipep-
tidyl peptidase IV antibody (40) (diluted 1:1000; gift from Werner
Reutter, Institute of Molecular Biology and Biochemistry, Free Univer-
sity of Berlin, Berlin, Germany), a rabbit polyclonal anti-HA antibody
(diluted 1:1000; Sigma), and a mouse monoclonal anti-acetylated -tu-
bulin antibody (diluted 1:200; Sigma). The following primary antibod-
ies were used on microwave-treated, paraffin-embedded sections: A
mouse monoclonal anti-HA antibody (diluted 1:100; Santa Cruz Bio-
technology, Santa Cruz, CA), a mouse monoclonal anti–Na
/K
-
ATPase antibody (diluted 1:200; Sigma), a mouse monoclonal anti–
proliferating cell nuclear antigen antibody (diluted 1:100,000; Sigma),
the mouse polyclonal anti–polycystin-2 antibody YCC2 (41) (diluted
1:5000; gift from Stefan Somlo and Yiqiang Cai, Yale University) and a
mouse monoclonal anti–Sat-1 antibody (42) (diluted 1:100; gift from
Birgitta Burckhardt, Zentrum Physiologie und Pathologie, Georg-
August-Universita ¨t, Go ¨ttingen, Germany). Primary antibodies were
incubated overnight at 4°C, then the sections were rinsed three times in
PBS and incubated with a Cy3- or FITC-coupled secondary antibody
(1:300; Dianova, Hamburg, Germany) for1ha troom temperature.
After washing in PBS, sections were mounted in bicarbonate-buffered
glycerol and visualized using the Zeiss laser confocal microscope LSM
510 Meta (Go ¨ttingen, Germany). When genomic DNA was to be visu-
alized, sections were incubated with 100 ng/ml of 4,6-diamidino-2-
phenylindole dihydrochloride as well. For Goldner’s trichrome and for
hematoxylin and eosin staining, paraffin sections were deparaffinized
and treated according to standard protocols.
Stably transfected LLC-PK1 cells were cultured on coverslips for at
least 2 d. After fixation with Bouin’s solution (0.1 M sodium phosphate
[pH 7.4], 15% saturated picric acid, and 2% formaldehyde) for 20 min,
the cells were permeabilized in 1 PBS, 2% BSA, and 0.1% Triton X-100
for 45 min and then incubated with the rabbit polyclonal anti-HA and
the mouse monoclonal anti-acetylated tubulin antibodies for2ha t
room temperature. After three washes with 1 PBS, the cells were
incubated with the FITC- and Cy3-conjugated secondary antibodies for
1 h at room temperature. Subsequently, the cells were washed with 1
PBS and mounted in bicarbonate-buffered glycerol. Pictures again were
taken with the Zeiss laser confocal microscope LSM 510 Meta.
Scanning Electron Microscopy
For scanning electron microscopy, rats were perfused with 2% glu-
taraldehyde and 1 PBS for 3 min at a pressure of 200 mmHg. After the
kidneys were postfixed in the same solution overnight, they were
dehydrated in increasing concentrations of acetone. Once the tissues
were equilibrated in 100% acetone, they were critical point–dried,
spudder-coated with gold, and finally imaged in a Zeiss DSM 940 A
scanning electron microscope.
Preparation of Total RNA and RNase Protection Assay
Organs of interest were removed rapidly, and total RNA was ex-
tracted according to the acid guanidinium-phenol-chloroform protocol
(43). RNA concentration was measured photometrically at 260 nm, and
integrity of the extracted RNA was checked by agarose gel electro-
phoresis. RNase protection analysis was performed according to stan-
dard protocols (33). A 180-bp fragment from the 3-untranslated region
and a 179-bp fragment from the 3-coding region of the transgene, both
of which do not cross-react with the endogenous rat Pkd2 mRNA; a
181-bp fragment of the rat Pkd2 cDNA; and an 80-bp 18S cDNA
fragment (Ambion, Austin, TX) were used for in vitro transcription with
32P-UTP. Twenty-five micrograms of total RNA was hybridized with
the radiolabeled mRNA-specific riboprobes, whereas 25 ng of total
RNA was hybridized with the radiolabeled 18S riboprobe; tRNA
served as a negative control. The expression levels of the transgene and
of the endogenous rat Pkd2 gene were compared by scanning the dried
polyacrylamide gels with a Fuji Image Reader FLA-5000 (Raytest
GmbH, Staubenhardt, Germany), processing the scans with ImageJ
software (W.S. Rasband, National Institutes of Health, Bethesda, MD;
http://rsb.info.nih.gov/ij/), and normalizing the obtained values to
the number of uridines in the riboprobes.
Immunoprecipitation
Cells were washed twice with 1 PBS and lysed in buffer that
contained 1% Triton X-100, 0.05% SDS, 150 mM NaCl, 10 mM Tris-HCl
(pH 7.5), 2 mM EDTA (pH 8.0), 1 g/ml of leupeptin, and 1 mM PMSF.
After centrifuging for 5 min at 14,000 rpm, the protein concentration
was determined according to an improved Bradford assay (44) using
the Protein Assay Kit from BioRad (Munich, Germany). For immuno-
precipitation, the indicated amounts of total protein were incubated for
90 min at 4°C with 50 l of supernatant from the 12CA5 hybridoma.
Then 25 l of swollen protein A–Sepharose beads was added to pre-
cipitate the immune complexes, followed by further incubation for 90
min at 4°C. Subsequently, the beads were washed twice with lysis
buffer, resuspended in 50 lo f1  SDS sample buffer (125 mM Tris-
HCl [pH 6.7], 2.5% SDS, 10% glycerol, 2.5% -mercaptoethanol, and
0.01% bromophenol blue), and incubated on ice for 30 min to elute the
precipitated proteins from the beads.
SDS-PAGE and Western Blotting
Proteins were separated on denaturing polyacrylamide gels without
previous boiling. The electrophoretic transfer of proteins from the gel
onto a polyvinylidene difluoride membrane (Millipore, Eschborn, Ger-
many) was carried out in a buffer that contained 50 mM Tris-HCl, 384
mM glycine, 20% methanol, and 0.1% SDS. After the transfer, the
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solution (5% low-fat dry milk powder, 0.05% Tween 20, and 1 PBS)
and then incubated for 2 h with the primary antibody. The following
primary antibodies were used: The mouse monoclonal anti–HA-
epitope antibody 12CA5 (diluted 1:25) and a mouse monoclonal anti–
His-epitope antibody (diluted 1:300; Roche Molecular Biochemicals,
Mannheim, Germany). After two washes with 0.5% Tween 20 in 1
PBS and two washes with blocking solution, the membrane was incu-
bated for 1 h with the horseradish peroxidase–conjugated anti-mouse
IgG secondary antibody (diluted 1:10,000; Sigma). To detect the blotted
proteins, we used a chemiluminescence detection kit (NEN Life Sci-
ence, Ko ¨ln, Germany).
Quantification of Cilia Length
The length of cilia was measured using the ImageJ software package.
Statistical Analyses
Statistical evaluations were performed using the TTEST procedure of
the statistical analysis system (SAS) from SAS Institute (Cary, NC).
Results
Synthesis of a Truncated Polycystin-2 Protein in Transgenic
Rats Leads to Renal Cyst Formation
We wanted to test whether additional mechanisms other
than a somatic mutation play a role in cyst formation by ex-
pressing a truncated human PKD2 cDNA in transgenic rats,
which were preferred over mice because they permit an easier
physiologic characterization. To this end, we have generated
two independent lines of transgenic Sprague-Dawley rats (line
111 and line 247) that synthesize a mutant polycystin-2 protein
that lacks the region beyond amino acid 703. This particular
polycystin-2 mutant was chosen because it lacks almost the
entire region of polycystin-2 extending into the cytoplasm (the
last membrane-spanning domain is predicted to end with
amino acid 679) and because several mutations that affect this
area were found in patients (45). Because the truncated protein
was tagged with an HA-epitope, it could be discerned easily
from the endogenous wild-type protein. The expression of the
transgene was controlled by the promoter/enhancer region of
the human CMV (Figure 1a), which is known for its strong
activity in a wide variety of tissues. Indeed, the transgene-
encoded mRNA was detected in many organs, although in both
lines the highest levels were produced in the kidneys (Figure
1b). Line 247 showed slightly higher expression levels of the
transgene, which may be because, according to Southern blot
analysis, line 111 carried approximately two copies and line 247
carried approximately five copies of the transgene (data not
shown). By RNase protection assay, we determined that in line
247 the kidneys contained approximately 15-fold and the eyes
(see below) approximately seven-fold higher levels of the trans-
gene-encoded mRNA than of the endogenous mRNA (data not
shown). As a first characterization, transgenic rats at 3 mo of
age were subjected to urine and serum analysis. In comparison
with age-matched Sprague-Dawley rats, the serum creatinine
concentration was significantly higher in line 247 and the uri-
nary excretion of total protein and albumin in line 111; all other
comparisons did not reach statistical significance (data not
shown). This trend toward renal insufficiency progressed when
the rats became older, and it became particularly evident in two
rats at 15 mo of age (Figure 1c). Renal damage can be due to
glomerular or tubular injury, and we therefore took a closer
look at the kidneys. Upon histologic examination by Goldner’s
trichrome staining, cystically dilated tubules were found pre-
dominantly in the renal cortex of both transgenic lines (Figure
1d). In agreement with the serum and urine analysis, which
showed some variability between rats, the degree of cyst for-
mation between rats of the same age varied. It was surprising to
see that in some kidneys, cysts obviously arose focally (Figure
1d). The trichrome staining also demonstrated a fibrotic remod-
eling of the kidneys that became very pronounced already at a
relatively young age in some rats (Figure 1d). No pathologic
changes were recognized in adrenal gland, brain, heart, large
and small intestine, liver, lung, salivary gland, spleen, and
testis.
The preponderance of cyst formation in the renal cortex
suggested that most cysts developed in proximal tubules. Us-
ing an antibody against the brush border enzyme dipeptidyl
peptidase IV, we were able to demonstrate that the majority of
cysts indeed originated from this nephron segment. Neither
dipeptidyl peptidase IV nor the basolateral proteins Na
/K
-
ATPase and Sat-1 were reproducibly missorted (Supplemental
Figure 1), thus arguing against a global change in cell polarity
as causing cyst formation. Furthermore, with the exception of
cysts in fibrotic areas (Supplemental Figure 2c), no obvious
difference in the proliferation rate could be detected between
proximal tubular and cyst-lining cells of transgenic rats and
proximal tubular cells of control rats (Supplemental Figure 2, a
and b). These data indicate that in our model, cell proliferation
does not contribute substantially to cystogenesis.
Truncated Polycystin-2 Protein Affects Cilia Formation in
Renal Epithelial Cells
If the formation of cysts in the transgenic rats occurred in a
cell-autonomous manner, then the truncated polycystin-2 pro-
tein should be produced at the site of cyst formation (i.e.,i n
proximal tubules). Immunohistochemistry with the anti–HA-
epitope antibody showed this to be the case. In normal and
cystic profiles, the brush border of many but not all proximal
tubules was labeled prominently for the truncated polycystin-2
protein; in cysts, the staining sometimes was seen in a mosaic
manner, indicative of the loss of brush border in certain areas of
the cysts (Figures 2a and 4d). Because it has been shown that
the wild-type polycystin-2 protein is present in the primary
cilium, we also double stained sections of the transgenic rat
kidneys with the anti–HA-epitope antibody and an antibody
against acetylated tubulin, a marker of primary cilia. It could be
seen clearly that the truncated polycystin-2 protein also traffics
to the primary cilium (Figure 2b). To corroborate our results in
the transgenic rats, we examined stably transfected LLC-PK1
cells that produced the same epitope-tagged truncated polycys-
tin-2 protein. In LLC-PK1 cells, we could find a strong staining
of the primary cilium, consistent with the pattern in the trans-
genic rat kidneys (Figure 2c).
It has been speculated that primary cilia serve a mechanosen-
sory role in the renal tubules and that by this mechanism, the
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references [46,47]). This prompted us to examine primary cilia
in the transgenic rat kidneys more closely by scanning electron
microscopy. Similar to what has been observed before in mouse
kidneys (48), primary cilia of proximal tubular epithelial cells
did not extend above the brush border in wild-type rat kidneys
(data not shown). That primary cilia are hidden in the brush
border became apparent in polycystic kidneys of transgenic
rats, where primary cilia were detected in the transition zone
between the intact brush border and denuded epithelium (data
not shown). Furthermore, in polycystic kidneys, we occasion-
ally observed that some cilia extended above the brush border,
a phenomenon that we never noticed in wild-type rat kidneys.
To find out whether the overshooting ciliary growth in proxi-
mal tubules of transgenic rats is a primary or a secondary
phenomenon, we turned our attention to stably transfected
LLC-PK1 cells that inducibly produced the truncated polycys-
tin-2 protein. In the “off” state, primary cilia had an average
length of 30.4 m (30.4  14.5 m, 1001 cilia). Upon induction
of the truncated polycystin-2 protein for 3 wk, primary cilia that
contained the mutant protein only grew to an average length of
21.0 m (21.0  10.7 m, 929 cilia; P  0.0001), indicating that
the truncated polycystin-2 protein stunted the extension of
primary cilia and that longer cilia in the transgenic rats are a
secondary phenomenon.
Expression of the PKD2 (1/703) cDNA Leads to
Degeneration of the Rod and Cone Layer in the Retina
In the retina, the outer segments of the rod and cone cells are
connected to the inner segments through a ciliary structure (49).
Remarkably, syndromes have been described whereby cystic
kidney disease is associated with retinal degeneration (e.g.,
references [50–52]); we therefore also looked for phenotypic
changes in the eyes of transgenic rats. When we previously
analyzed the expression pattern of the rat Pkd2 gene, we were
able to detect polycystin-2 only in the cornea (53), but because
according to the UniGene database the PKD2 mRNA should be
present in the retina, we carried out another immunohisto-
chemical study, this time using microwave treatment of the
sections. Indeed, we were able to detect the endogenous poly-
cystin-2 protein in the retina (Figure 4c). Similarly, the trun-
cated polycystin-2 protein was present in the somata and the
photoreceptor segments of rod and cone cells of the transgenic
rats (Figure 3, a through c). This histologic finding correlated
well with the phenotypic changes that we observed in the
retinas of both transgenic lines. Whereas at 1 mo of age we did
not detect a difference between the retina of the transgenic and
wild-type rats, the rod and cone layer of the transgenic animals
had shrunk markedly at 3 mo (Figure 3, a through d). Remark-
ably, the degeneration of the retina was accompanied by the
dishevelled appearance of microtubule-containing structures
that likely represent connecting cilia (Figure 3, e and f).
Hints on the Possible Mechanism Underlying Cyst
Formation
There are several possibilities for how a truncated polycys-
tin-2 protein can induce renal cyst formation in the presence of
the wild-type polycystin-2 protein. We first tested whether
full-length and truncated polycystin-2 still can interact, thereby
possibly forming cation channels with abnormal electrophysi-
ologic properties. It has been shown that the COOH-terminus
of polycystin-2 can interact with itself (13,14), but these earlier
experiments were conducted in vitro, in yeast and in mamma-
lian cells, using fusion proteins with only the COOH-terminus
of polycystin-2. So far, a homomeric interaction has not been
demonstrated for the full-length polycystin-2 protein in mam-
Figure 2. Localization of the truncated polycystin-2 protein. (a)
The HA-epitope–tagged truncated polycystin-2 protein was de-
tected on kidney sections by staining with the anti–-HA-
epitope antibody. In both transgenic lines, the protein is present
in the brush border. (b) Double staining with an antibody
against the HA-epitope (HA) and against acetylated tubulin
also shows the presence of the truncated polycystin-2 protein in
primary cilia (arrows). Given the fine structure of primary cilia,
longer exposure times had to be taken to visualize the cilia,
resulting in the extremely bright signal of the brush border. (c)
In transfected LLC-PK1 cells, the truncated, epitope-tagged
polycystin-2 protein again is present in primary cilia (arrow) as
demonstrated by double staining for the HA-epitope (HA) and
acetylated tubulin. Bars  50 m (a) and 25 m (b and c).
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mains in polycystin-2 also can mediate a homomeric interac-
tion. By establishing stably transfected cells that produce a
His-tagged full-length polycystin-2 protein together with either
an HA-tagged full-length or an HA-tagged truncated polycys-
tin-2 protein, we were able to demonstrate a homomeric inter-
action for the full-length polycystin-2 protein but not between
the truncated and the full-length protein (Figure 4a). Therefore,
the self-interaction of full-length polycystin-2 should not be
prevented by the truncated protein, and functional polycystin-2
channels still should be allowed to form. Another explanation
for the phenotypic changes in the transgenic rats could be a
transgene-induced mislocalization of the endogenous polycys-
tin-2 protein or a change in the levels of the endogenous rat
Pkd2 mRNA. However, in both the wild-type and the trans-
genic rats, the endogenous polycystin-2 protein still was
present in the basal compartment and in cilia of proximal
tubular epithelial cells (Figure 4, b, d, and e) and in retinal
photoreceptor cells (Figure 4, c and f). Furthermore, both in the
eyes and in the kidneys, the levels of the endogenous Pkd2
mRNA were the same in wild-type and transgenic rats as
determined by RNase protection assay (data not shown).
Because the truncated polycystin-2 protein obviously did not
affect the full-length polycystin-2 protein directly, we next
sought to find evidence of whether the mutant protein had an
effect on intracellular calcium levels. Several reports have ar-
gued that the activation of purinergic receptors through ATP
increases the secretory activity of cyst wall epithelia (54–56).
We therefore examined how stably transfected LLC-PK1 cells
that inducibly produced either full-length or the truncated
polycystin-2 protein reacted to ATP. Whereas induction of the
full-length protein enhanced the Ca
2 response of LLC-PK1
cells to ATP as judged by the peak of the [Ca
2]i, the synthesis
of the truncated polycystin-2 protein did not change the [Ca
2]i
after stimulation of the cells with ATP (Figure 5a). Because in
LLC-PK1 cells we have localized the full-length polycystin-2
protein to the endoplasmic reticulum, we also measured the
release of Ca
2 from intracellular stores by exposing LLC-PK1
cells to the Ca
2 ionophore ionomycin. Remarkably, LLC-PK1
cells that produced the truncated polycystin-2 protein released
less Ca
2 into the cytoplasm, thereby indicating that the endo-
plasmic reticulum contained less Ca
2 (Figure 5b).
Discussion
We have generated a new rat model of ADPKD by express-
ing a truncated human polycystin-2 cDNA in Sprague-Dawley
rats. Although we used the widely active CMV promoter to
drive the transgenic expression cassette and although we ob-
served expression in a large number of tissues, no histologic
abnormalities were detected in most tissues. Whether this ob-
servation is due to the high expression levels of the transgenic
cassette in the kidney or emphasizes the particular sensitivity of
some tissues to the mutated polycystin-2 protein remains an
open question for now. It also was surprising to see that in both
transgenic lines the transgenic cassette was expressed predom-
inantly in proximal tubules, for which we have no explanation.
We want to point out, however, that cysts have been observed
regularly in proximal tubules of patients (57–61) and that there-
fore our transgenic rats do not differ from the human disease in
this respect.
A cystic phenotype in two independent transgenic lines
strongly supports the argument that the overexpression of the
truncated polycystin-2 cDNA is responsible for the kidney
damage and argues against the hypothesis that the integration
of the transgenic cassette into a specific locus leads to the
formation of cysts. Similar to what has been observed in human
ADPKD, the transgenic rats developed fibrosis and showed
focal cyst formation. Although an explanation for the latter
could be the known mosaic activity of the CMV promoter, we
cannot rule out other factors, such as a particular microenvi-
Figure 3. Retinal degeneration in transgenic line 247. Immuno-
histochemistry (a) with an anti-HA antibody localizes the HA-
epitope–tagged truncated polycystin-2 protein to the outer nu-
clear layer (ONL) and the rod and cone layer (R/C) as
demonstrated by counterstaining the nuclei with 4,6-dia-
midino-2-phenylindole dihydrochloride (b; merged in c). (d) By
hematoxylin and eosin staining, it can be appreciated easily
that the ONL and the R/C of the retina have shrunk in 3-mo-
old transgenic rats. (e and f) Staining for acetylated tubulin
demonstrates the parallel arrangement of connecting cilia in the
retinas of normal SD rats and the dishevelled appearance of
microtubule-containing structures in the degenerated retina of
transgenic line 247 (TGR). Bars  50 m (a through d) and 20
m (e and f).
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verity between animals. It has to be remembered, however, that
the transgenic rats were established on a Sprague-Dawley back-
ground, which is an outbred rat strain, and that the genetic
background of the various animals therefore probably is heter-
ogeneous. Crosses are under way to transfer the transgene into
an inbred rat strain to determine more precisely the effect of the
genetic background.
It has been estimated that renal cysts in patients with
ADPKD develop in only approximately 5% of the nephrons.
This observation is puzzling in light of the dominant inheri-
tance of the disease, but it can be explained by the two-hit
hypothesis, which in analogy to the action of tumor suppressor
genes states that a second somatic mutation is required for cyst
formation (28). Support for this mechanism has been gained
from a mouse model, in which an unstable Pkd2 allele was
Figure 4. Interaction between full-length and truncated polycystin-2, and distribution of the endogenous polycystin-2 protein in
transgenic rats. (a) Immunoprecipitations (IP) were performed with stably transfected HeLa cells that inducibly produced either
histidine- and HA-epitope–tagged full-length polycystin-2 (left side of each panel) or histidine-tagged full-length and HA-
epitope–tagged truncated polycystin-2 proteins (right side of each panel). IP and subsequent incubation of the Western blot with
the anti–HA-epitope antibody demonstrates the expression of the HA-epitope–tagged full-length and truncated polycystin-2
proteins (left; to correct for the different expression levels, 10 g of total protein was used in the case of the full-length protein and
100 g of total protein in the case of the truncated protein). When the IP was carried out with the anti–HA-epitope antibody and
the Western blot was incubated with the anti–histidine-tail antibody, it becomes evident that only the full-length proteins interact
with each other (middle; to correct for the different expression levels of the HA-epitope–tagged polycystin-2 proteins, 90 go f
total protein was used in the case of the full-length protein and 900 g of total protein in the case of the truncated protein). The
synthesis of the histidine-tagged full-length polycystin-2 protein was demonstrated by analysis of total cell lysate with the
anti–histidine-tail antibody (right; 8 g of total protein was loaded when the full-length proteins were coexpressed, and 30 go f
total protein was loaded when the full-length and truncated proteins were coexpressed). Arrow, full-length polycystin-2;
arrowhead, truncated polycystin-2. (b) The endogenous polycystin-2 protein in a wild-type SD rat is located in the basal
compartment of proximal tubular epithelial cells. (c) In the retina of a normal SD rat, the endogenous polycystin-2 was present
in the ganglion cell layer (G), the inner nuclear layer (INL), the ONL, and the R/C of the photoreceptor cells (the arrowhead points
to the presumable inner segment of the photoreceptor cells). (d and e) In cyst wall cells, the endogenous polycystin-2 protein
(green) still is present in the basal compartment (d) and in cilia (e), whereas the truncated polycystin-2 (red) is detected in the
brush border (d). The arrows in d point to two areas where the truncated protein is absent. (f) In the retina of transgenic rats, the
endogenous polycystin-2 protein (green) still was synthesized in the dysmorphic R/C of the photoreceptor cells, whereas the
truncated polycystin-2 (red) is detected in the ONL and the R/C (the arrowhead points to the presumable inner segment of the
photoreceptor cells). Bars  25 m (b) and 50 m (c through f).
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bination to form a null allele (29,30). Therefore, although the
pattern of inheritance is dominant, the disease behaves in a
recessive manner on a cellular level, and such a scenario could
explain easily the focal nature of cyst formation and the slowly
progressive course of the disease, which usually takes decades
before it leads to end-stage renal failure. There are some open
questions regarding the two-hit hypothesis, however, such as
why a somatic mutation in the second allele has not been found
in 100% of the cysts examined, why polycystin-2 still was
detected by immunohistochemistry in many cyst-lining epithe-
lial cells (see references in [6]), and why in the cpk/cpk mouse
model of autosomal recessive polycystic kidney disease cysts
also develop focally (62,63). Although our results certainly do
not contradict the two-hit hypothesis, they suggest an addi-
tional mechanism of cystogenesis by attributing a role to the
mutated polycystin-2 protein. Such a hypothesis is supported
by the finding that LLC-PK1 cells elaborate shorter cilia in the
presence of the mutated polycystin-2 protein. Consistent with
this in vitro result is the degeneration of the retinal photorecep-
tor cells, whereas the overshooting ciliary growth that we ob-
served on some cyst-lining epithelial cells has to be considered
a secondary phenomenon.
The full-length polycystin-2 protein has the characteristics
of a high-conductance, Ca
2-modulated cation channel that
is permeable to mono- and divalent ions, whereas the 703–
amino acid mutant protein, which was used in this study,
still has some channel activity but no longer responds to
Ca
2 (35). Because the wild-type and the truncated polycys-
tin-2 proteins no longer can interact, a direct modulation of
the full-length by the truncated polycystin-2 protein is un-
likely; rather, the truncated polycystin-2 protein may cause
cyst formation by acting as a dysregulated channel in itself.
However, we cannot rule out that precise polycystin-2 levels
have to be maintained and that overexpression of the mutant
PKD2 cDNA per se leads to cyst formation. In the case of
polycystin-1, there is precedence that levels of polycystin-1
that are both too low (64,65) and too high (66,67) lead to the
development of polycystic kidneys. Additional copies of a
PKD gene therefore can result in cyst formation, and further
Figure 5. Ca
2 response and intracellular Ca
2 stores in LLC-PK1 cells that inducibly produced the truncated polycystin-2 protein.
(a) Stably transfected LLC-PK1 cells that inducibly produced either a HA-tagged full-length or truncated polycystin-2 protein were
stimulated with 10 M ATP at 20 s into the experiment. The induction of the full-length polycystin-2 protein by removing
doxycycline led to a higher [Ca
2]i peak, whereas the induction of the truncated polycystin-2 protein had no effect on the [Ca
2]i.
The parent cell line (control cells), which was grown in the absence and presence of doxycycline, was used as a negative control.
(b) For determination of the status of the intracellular Ca
2 stores, the stably transfected LLC-PK1 cells were incubated in Ca
2-free
buffer and then exposed to 10 M ionomycin at 20 s into the experiment. In cells that produced the truncated polycystin-2 protein,
the stores were less filled, but no difference was seen when the full-length polycystin-2 protein was induced. Again, the parent
cell line, grown in the absence and presence of doxycycline, was used as a negative control. Shown are the mean and the SD. *P 
0.001 for peak [Ca
2]i.
J Am Soc Nephrol 17: 2719–2730, 2006 Truncated Polycystin-2 Causes PKD 2727experiments, such as a knock-in approach, are necessary to
decide whether cyst formation in our transgenic rats results
from an abnormal biologic activity of the truncated protein
(e.g., by a dominant negative mechanism) or simply is due to
the high levels of the mutant polycystin-2 protein. If the first
hypothesis is correct, then gene therapy that is based on the
introduction of the wild-type protein is unlikely to succeed
because it will not affect the mutant protein.
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